Abstract

Postprandial IL-1β surges are predominant in the white adipose tissue (WAT), but its consequences are unknown. Here, we investigate the role of IL-1β in WAT energy storage and show that adipocyte-specific deletion of IL-1 receptor 1 (IL1R1) has no metabolic consequences, whereas ubiquitous lack of IL1R1 reduces body weight, WAT mass, and adipocyte formation in mice. Among all major WAT-resident cell types, progenitors express the highest IL1R1 levels. In vitro, IL-1β potently promotes adipogenesis in murine and human adipose-derived stem cells. This effect is exclusive to early-differentiation-stage cells, in which the adipogenic transcription factors C/EBPδ and C/EBPβ are rapidly upregulated by IL-1β and enriched near important adipogenic genes. The pro-adipogenic, but not pro-inflammatory effect of IL-1β is potentiated by acute treatment and blocked by chronic exposure. Thus, we propose that transient postprandial IL-1β surges regulate WAT remodeling by promoting adipogenesis, whereas chronically elevated IL-1β levels in obesity blunts this physiological function.

The consequences of postprandial IL-1β surges in white adipose tissue are unknown. Here the authors show IL-1β regulates WAT remodelling by promoting adipogenesis and energy storage, which is blocked by chronic elevation of this cytokine (as in obesity).

Details

Title
IL-1β promotes adipogenesis by directly targeting adipocyte precursors
Author
Hofwimmer, Kaisa 1 ; de Paula Souza, Joyce 2 ; Subramanian, Narmadha 1 ; Vujičić, Milica 3   VIAFID ORCID Logo  ; Rachid, Leila 2 ; Méreau, Hélène 2 ; Zhao, Cheng 2 ; Dror, Erez 2 ; Barreby, Emelie 4   VIAFID ORCID Logo  ; Björkström, Niklas K. 4   VIAFID ORCID Logo  ; Wernstedt Asterholm, Ingrid 3   VIAFID ORCID Logo  ; Böni-Schnetzler, Marianne 2   VIAFID ORCID Logo  ; Meier, Daniel T. 2   VIAFID ORCID Logo  ; Donath, Marc Y. 2   VIAFID ORCID Logo  ; Laurencikiene, Jurga 1   VIAFID ORCID Logo 

 Karolinska Institutet, Lipid Laboratory, Unit of Endocrinology, Department of Medicine Huddinge, Huddinge, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626) 
 University of Basel and University Hospital Basel, Department of Biomedicine, Basel, Switzerland (GRID:grid.6612.3) (ISNI:0000 0004 1937 0642); University Hospital Basel, Clinic of Endocrinology, Diabetes and Metabolism, Basel, Switzerland (GRID:grid.410567.1) (ISNI:0000 0001 1882 505X) 
 The Sahlgrenska Academy at University of Gothenburg, Department of Physiology/Metabolic Physiology, Institute of Neuroscience and Physiology, Gothenburg, Sweden (GRID:grid.8761.8) (ISNI:0000 0000 9919 9582) 
 Karolinska Institutet, Karolinska University Hospital, Center for Infectious Medicine, Department of Medicine Huddinge, Huddinge, Sweden (GRID:grid.24381.3c) (ISNI:0000 0000 9241 5705) 
Pages
7957
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3103047617
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.